Back to Results
First PageMeta Content
Aging-associated diseases / Medical emergencies / Direct thrombin inhibitors / Prodrugs / Hematology / Dabigatran / Warfarin / Myocardial infarction / Stroke / Chemistry / Organic chemistry / Medicine


Addendum to Clinical Review for NDA[removed]Drug: Sponsor:
Add to Reading List

Open Document

File Size: 294,83 KB

Share Result on Facebook

City

Silent / /

Company

ITT / /

Currency

INR / /

Event

FDA Phase / /

IndustryTerm

stroke prevention / clinical site / Prevention of stroke / keyword search / /

MedicalCondition

hypertension / cardiomyopathy / Acute Coronary Syndromes / Typical prolonged severe chest pain / cardiac failure / MI heart failure / systemic embolism / congestive cardiomyopathy / non-ST-segment myocardial infarction / stroke / diabetes / unstable angina / myocardial infarction / embolism / heart failure / serious unstable angina / infarction myocardial infarction / venous thromboembolism / coronary artery disease / LV dysfunction / pulmonary embolism / atrial fibrillation / death Angina Pectoris / W cardiac failure / death Coronary artery disorder / ischemic cardiomyopathy / acute myocardial infarction / /

MedicalTreatment

invasive procedures / total knee replacement / /

Organization

FDA / Division of Cardiovascular and Renal Products Nhi Beasley Subject / /

/

Product

clopidogrel / ximelagatran / /

ProvinceOrState

Michigan / /

PublishedMedium

Baseline / /

Technology

CAD / /

SocialTag